Vivani Medical Inc
VANI
Company Profile
Business description
Vivani Medical Inc is a clinical-stage biopharmaceutical company whose primary focus is the development of miniature subdermal drug implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases with once or twice-yearly administration. Its flagship drug implant candidates are designed to improve medication adherence and provide smooth, consistent therapeutic levels of GLP-1, the same class of active pharmaceutical ingredients used in Ozempic, Trulicity, and Wegovy.
Contact
1350 South Loop Road
AlamedaCA94502
USAT: +1 415 506-8462
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
36
Stocks News & Analysis
stocks
US dividend shares are getting a boost rrom the HALO rrade. Can it last?
Both high-dividend stocks and dividend-growth stocks are outperforming amid AI disruption.
stocks
Unconventional wisdom: A modern day bank run
Is the economy and investor portfolios at risk from a potential a ‘bank run’ in private credit?
stocks
Shares leap for ASX rare earths provider
We increased our fair value based on higher expected rare earths pricing.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,824.50 | 11.70 | 0.13% |
| CAC 40 | 7,984.44 | 72.92 | -0.91% |
| DAX 40 | 23,589.65 | 50.38 | -0.21% |
| Dow JONES (US) | 46,677.85 | 739.42 | -1.56% |
| FTSE 100 | 10,305.15 | 48.62 | -0.47% |
| HKSE | 25,716.76 | 182.00 | -0.70% |
| NASDAQ | 22,311.98 | 404.16 | -1.78% |
| Nikkei 225 | 54,452.96 | 572.41 | -1.04% |
| NZX 50 Index | 13,148.04 | 51.25 | -0.39% |
| S&P 500 | 6,672.62 | 103.18 | -1.52% |
| S&P/ASX 200 | 8,604.00 | 16.10 | 0.19% |
| SSE Composite Index | 4,129.10 | 4.33 | -0.10% |